Amwell® Announces Results for Fourth Quarter and Full Year 2025
Rhea-AI Summary
Amwell (NYSE: AMWL) announced fourth-quarter and full-year 2025 financial results and will host a conference call today, Feb 12, 2026, at 5:00 p.m. ET.
The company said investors can view the earnings release and access a live audio webcast at the provided link; a replay will be available for ~90 days on the investor site.
Positive
- None.
Negative
- None.
News Market Reaction – AMWL
In the Feb 13 session, AMWL gained 24.71%, reflecting a significant positive market reaction. Argus tracked a peak move of +26.4% during that session. Argus tracked a trough of -3.4% from its starting point during tracking. Our momentum scanner triggered 34 alerts that day, indicating elevated trading interest and price volatility. Trading volume was very high at 4.4x the daily average, suggesting strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 04 | Q3 2025 earnings | Neutral | -0.8% | Reported Q3 2025 results and held standard earnings call and webcast. |
| Aug 05 | Q2 2025 earnings | Neutral | -7.3% | Announced Q2 2025 results with scheduled earnings call and webcast replay. |
| May 01 | Q1 2025 earnings | Neutral | +19.7% | Released Q1 2025 financials and hosted a 5 p.m. ET conference call. |
| Feb 12 | FY/Q4 2024 earnings | Neutral | -5.0% | Reported Q4 and full-year 2024 financial results with accompanying webcast. |
| Oct 30 | Q3 2024 earnings | Neutral | -5.1% | Posted Q3 2024 financial results and held same-day earnings call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings releases have produced mixed but generally modest moves, averaging about 0.3% over the last five comparable announcements.
Over the last five earnings releases from Oct 2024 through Nov 2025, Amwell has consistently announced quarterly or annual results with an investor call and webcast. Price reactions ranged from about -7.31% to +19.71%, with an average move of 0.3%, showing variable but often contained responses. This new fourth quarter and full year 2025 release continues that cadence of regular financial updates and conference calls.
Key Terms
saas-based technical
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2025. The company’s fourth quarter and full year 2025 earnings report can be viewed at investors.amwell.com.
Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/7o2zjx2o/. A webcast replay will be available for approximately 90 days at investors.amwell.com.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Contacts
Media:
press@amwell.com
Investors:
Asher Dewhurst
amwell@icrhealthcare.com